Michael Gerard's most recent trade in ContextLogic Inc - Ordinary Shares - Class A was a trade of 11,870 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ContextLogic Inc Ordinary | Michael Gerard Scarola | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 11,870 | 11,870 | - | - | Restricted Stock Units | |
| ContextLogic Inc Ordinary | Michael Gerard Scarola | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.05 per share. | 19 Nov 2025 | 4,485 | 7,385 | - | 7.0 | 31,619 | Common Stock |
| ContextLogic Inc Ordinary | Michael Gerard Scarola | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2025 | 11,870 | 11,870 | - | - | Restricted Stock Units | |
| ContextLogic Inc Ordinary | Michael Gerard Scarola | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2025 | 11,870 | 11,870 | - | 0 | Common Stock | |
| ContextLogic Inc Ordinary | Michael Gerard Scarola | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 23,740 | 23,740 | - | - | Restricted Stock Units | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 112,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |